Acta Vet. Brno 2023, 92: 79-88

https://doi.org/10.2754/avb202392010079

Effect of Tarantula cubensis alcoholic extract on tumour pathways in azoxymethane-induced colorectal cancer in rats

Gokhan Akcakavak1, Ozgur Ozdemır2

1Yozgat Bozok University, Faculty of Veterinary Medicine, Department of Pathology, Sorgun, Yozgat, Türkiye
2Selcuk University, Faculty of Veterinary Medicine, Department of Pathology, Selcuklu, Konya, Türkiye

Received April 3, 2022
Accepted December 8, 2022

References

1. Al-Numair KS, Waly MI, Ali A, Essa MM, Farhat MF, Alsaif MA 2011: Dietary folate protects against azoxymethane-induced aberrant crypt foci development and oxidative stress in rat colon. Exp Biol Med 236: 1005-1011 <https://doi.org/10.1258/ebm.2011.011010>
2. Amaral JD, Xavier JM, Steer CJ, Rodrigues CM 2010: The role of p53 in apoptosis. Dis Med 9: 145-152
3. Ashokkumar P, Sudhandiran G 2011: Luteolin inhibits cell proliferation during Azoxymethane-induced experimental colon carcinogenesis via Wnt/β-catenin pathway. Inves New Drugs 29: 273-284 <https://doi.org/10.1007/s10637-009-9359-9>
4. Bian J, Dannappel M, Wan C, Firestein R 2020: Transcriptional regulation of Wnt/β-catenin pathway in colorectal cancer. Cells 9: 2125 <https://doi.org/10.3390/cells9092125>
5. Caderni G 1997: APC mutations in aberrant crypt foci and colonic tumors induced by azoxymethane in rats. Proc Am Assoc Cancer Res 38: 467
6. Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J 2016: Cancer statistics in China. 2015. CA: Cancer J Clin 66: 115-132
7. Cunningham D, Atkin W, Lenz H, Lynch HT, Minsky B, Nordlinger B 2010: Colorectal cancer. Lancet 375: 1030-1047 <https://doi.org/10.1016/S0140-6736(10)60353-4>
8. Day C, Saxton J 1998: Veterinary Homeopathy: Principles and Practice. In: Schoen AM, Wynn SG (Eds): Complementary and Alternative Veterinary Medicine. First edn, St Louis, Missouri, USA, pp. 485-514
9. Di̇k B, Er A, Corum O 2014: Effect of alcoholic extract of Tarantula cubensis (Theranekron®) on serum thiobarbituric acid-reactive species concentrations in sheep. Eurasian J Vet Sci 30: 68-71
10. Er A, Ozdemir O, Coskun D, Dik B, Bahcivan E, Faki HE, Yazar E 2019: Effects of Tarantula cubensis alcoholic extract and Nerium oleander distillate on experimentally induced colon cancer development. Rev Med Vet 45: 47
11. Erdman SH, Wu HD, Hixson LJ, Ahnen DJ, Gerner EW 1997: Assessment of mutations in Ki-ras and p53 in colon cancers from azoxymethane‐and dimethylhydrazine-treated rats. Published in cooperation with the University of Texas MD Anderson Cancer Center. Mol Carcinog 19: 137-144 <https://doi.org/10.1002/(SICI)1098-2744(199707)19:2<137::AID-MC8>3.0.CO;2-C>
12. Erster S, Mihara M, Kim RH, Petrenko O, Moll UM 2004: In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation. Mol Cell Biol 24: 6728-6741 <https://doi.org/10.1128/MCB.24.15.6728-6741.2004>
13. Fearon ER, Vogelstein B 1990: A genetic model for colorectal tumorigenesis. Cell 61: 759-767 <https://doi.org/10.1016/0092-8674(90)90186-I>
14. Ferraz da Costa DC, Pereira Rangel L, Martins-Dinis MMDDC, Ferretti GDDS, Ferreira VF, Silva JL 2020: Anticancer potential of resveratrol, β-lapachone and their analogues. Molecules 25: 893 <https://doi.org/10.3390/molecules25040893>
15. Fichera A, Little N, Jagadeeswaran S, Dougherty U, Sehdev A, Mustafi R, Cerda S, Yuan W, Khare S, Tretiakova M 2007: Epidermal growth factor receptor signaling is required for microadenoma formation in the mouse azoxymethane model of colonic carcinogenesis. Cancer Res 67: 827-835 <https://doi.org/10.1158/0008-5472.CAN-05-3343>
16. Ghasemi-Dizgah A, Nami B, Amirmozafari N 2017: Tarantula cubensis venom (Theranekron®) selectively destroys human cancer cells via activating caspase-3-mediated apoptosis. Acta Medica Int 4: 74
17. Giles RH, Van Es JH, Clevers H 2003: Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta Rev Cancer 1653: 1-24 <https://doi.org/10.1016/S0304-419X(03)00005-2>
18. Gultiken N, Guvenc T, Kaya D, Agaoglu AR, Ay SS, Kucukaslan I, Emre B, Findik M, Schäfer-Somi S, Aslan S 2015: Tarantula cubensis extract alters the degree of apoptosis and mitosis in canine mammary adenocarcinomas. J Vet Sci 16: 213-219 <https://doi.org/10.4142/jvs.2015.16.2.213>
19. Gültiken N, Vural MR 2007: The effect of Tarantula cubensis extract applied in pre and postoperative period of canine mammary tumours. J İstanbul Vet Sci 2: 13-23
20. Halaby M-J, Harris BR, Miskimins WK, Cleary MP, Yang D-Q 2015: Deregulation of internal ribosome entry site-mediated p53 translation in cancer cells with defective p53 response to DNA damage. Mol Cell Biol 35: 4006-4017 <https://doi.org/10.1128/MCB.00365-15>
21. He T-C, Sparks AB, Rago C, Hermeking H, Zawel L, Da Costa LT, Morin PJ, Vogelstein B, Kinzler KW 1998: Identification of c-MYC as a target of the APC pathway. Science 281: 1509-1512 <https://doi.org/10.1126/science.281.5382.1509>
22. Herbst A, Kolligs FT 2007: Wnt signaling as a therapeutic target for cancer. Target Discovery and Validation Reviews and Protocols 361: 63-91 <https://doi.org/10.1385/1-59745-208-4:63>
23. Hernández-Salazar M, Guevara-González RG, Cruz-Hernández A, Guevara-Olvera L, Bello-Pérez LA, Castaño-Tostado E, Loarca-Piña G 2013: Flaxseed (Linum usitatissimum L.) and its total non-digestible fraction influence the expression of genes involved in azoxymethane-induced colon cancer in rats. Plant Foods Hum Nutr 68: 259-267 <https://doi.org/10.1007/s11130-013-0372-y>
24. Hu Y, Le Leu RK, Young GP 2009: Detection of K-ras mutations in azoxymethane-induced aberrant crypt foci in mice using LNA-mediated real-time PCR clamping and mutant-specific probes. Mutat Res Genet Toxicol Environ Mutagen 677: 27-32 <https://doi.org/10.1016/j.mrgentox.2009.05.003>
25. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ 2008: Cancer statistics. CA: Cancer J Clin 58: 71-96
26. Karabacak M, Eraslan G, Kanbur M, Sarıca ZS 2015: Effects of Tarantula cubensis D6 on aflatoxin-induced injury in biochemical parameters in rats. Homeopathy 104: 205-210 <https://doi.org/10.1016/j.homp.2015.02.005>
27. Khare S, Cerda S, Wali RK, Von Lintig FC, Tretiakova M, Joseph L, Stoiber D, Cohen G, Nimmagadda K, Hart J 2003: Ursodeoxycholic acid inhibits Ras mutations, wild-type Ras activation, and cyclooxygenase-2 expression in colon cancer. Cancer Res 63: 3517-3523
28. Kishimoto Y, Takata N, Jinnai T, Morisawa T, Shiota G, Kawasaki H, Hasegawa J 2000: Sulindac and a cyclooxygenase-2 inhibitor, etodolac, increase APC mRNA in the colon of rats treated with azoxymethane. Gut 47: 812-819 <https://doi.org/10.1136/gut.47.6.812>
29. Kishimoto Y, Yashima K, Morisawa T, Shiota G, Kawasaki H, Hasegawa J 2002: Effects of cyclooxygenase-2 inhibitor NS-398 on APC and c-myc expression in rat colon carcinogenesis induced by azoxymethane. J Gastroenterol 37: 186-193 <https://doi.org/10.1007/s005350200019>
30. Kure S, Nosho K, Baba Y, Irahara N, Shima K, Ng K, Meyerhardt JA, Giovannucci EL, Fuchs CS, Ogino S 2009: Vitamin D receptor expression is associated with PIK3CA and KRAS mutations in colorectal cancer. Cancer Epidemiol Biomark Prev 18: 2765-2772 <https://doi.org/10.1158/1055-9965.EPI-09-0490>
31. Lai CS, Li S, Liu CB, Miyauchi Y, Suzawa M, Ho CT, Pan MH 2013: Effective suppression of azoxymethane-induced aberrant crypt foci formation in mice with citrus peel flavonoids. Mol Nutr Food Res 57: 551-555 <https://doi.org/10.1002/mnfr.201200606>
32. Li J, Mizukami Y, Zhang X, Jo W-S, Chung DC 2005: Oncogenic K-ras stimulates Wnt signaling in colon cancer through inhibition of GSK-3β. Gastroenterology 128: 1907-1918 <https://doi.org/10.1053/j.gastro.2005.02.067>
33. Mattiuzzi C, Lippi G 2019: Current cancer epidemiology. J Epidemiol Glob Health 9: 217-222 <https://doi.org/10.2991/jegh.k.191008.001>
34. Migliore L, Migheli F, Spisni R, Coppedè F 2011: Genetics, cytogenetics, and epigenetics of colorectal cancer. J Biomed Biotechnol 2011: 792362 <https://doi.org/10.1155/2011/792362>
35. Müller M, Wilder S, Bannasch D, Israeli D, Lehlbach K, Li-Weber M, Friedman SL, Galle PR, Stremmel W, Oren M 1998: p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs. J Exp Med 1998 188: 2033-2045
36. Norazalina S, Norhaizan M, Hairuszah I, Norashareena M 2010: Anticarcinogenic efficacy of phytic acid extracted from rice bran on azoxymethane-induced colon carcinogenesis in rats. Exp Toxicol Pathol 62: 259-268 <https://doi.org/10.1016/j.etp.2009.04.002>
37. Orlando FA, Tan D, Baltodano JD, Khoury T, Gibbs JF, Hassid VJ, Ahmed BH, Alrawi SJ 2008: Aberrant crypt foci as precursors in colorectal cancer progression. J Surg Oncol 98: 207-213 <https://doi.org/10.1002/jso.21106>
38. Pallem PVSP, Bodiga S, Bodiga VL 2020: Dietary phytate lowers K-ras mutational frequency, decreases DNA-adduct and hydroxyl radical formation in azoxymethane-induced colon cancer. Iran J Basic Med Sci 23: 20
39. Papanikolaou A, Wang Q-S, Papanikolaou D, Whiteley HE, Rosenberg DW 2000: Sequential and morphological analyses of aberrant crypt foci formation in mice of differing susceptibility to azoxymethane-induced colon carcinogenesis. Carcinogenesis 21: 1567-1572 <https://doi.org/10.1093/carcin/21.8.1567>
40. Pfaffl MW 2001: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45 <https://doi.org/10.1093/nar/29.9.e45>
41. Richter Pharma 2018: https://www.richter-pharma.at/product-theranekron-d6_301.htm. Accessed June 4, 2018
42. Qureshi UF, Aslam MN, Ansari MN, Khan M 2018: Role of aspirin as prophylaxis against colorectal cancer. J Postgrad Med Inst 29: 16-19
43. Refaat B, El-Shemi AG, Kensara OA, Mohamed AM, Idris S, Ahmad J, Khojah A 2015: Vitamin D3 enhances the tumouricidal effects of 5-Fluorouracil through multipathway mechanisms in azoxymethane rat model of colon cancer. J Exp Clin Cancer Res 34: 1-15 <https://doi.org/10.1186/s13046-015-0187-9>
44. Richardson-Boedler C 2002: The brown spider Loxosceles laeta: source of the remedy Tarentula cubensis? Homeopathy 91: 166-170 <https://doi.org/10.1054/homp.2002.0029>
45. Sax JK, Fei P, Murphy ME, Bernhard E, Korsmeyer SJ, El-Deiry WS 2002: BID regulation by p53 contributes to chemosensitivity. Nat Cell Biol 4: 842-849 <https://doi.org/10.1038/ncb866>
46. Schulz W 2005: Molecular Biology of Human Cancers: An Advanced Student’s Textbook. Springer Science & Business Media press, Dordrecht, Netherlands, 508 p.
47. Sepporta MV, Fuccelli R, Rosignoli P, Ricci G, Servili M, Fabiani R 2016: Oleuropein prevents azoxymethane-induced colon crypt dysplasia and leukocytes DNA damage in A/J mice. J Med Food 19: 983-989 <https://doi.org/10.1089/jmf.2016.0026>
48. Singh VK, Arora D, Ansari MI, Sharma PK 2019: Phytochemicals based chemopreventive and chemotherapeutic strategies and modern technologies to overcome limitations for better clinical applications. Phytother Res 33: 3064-3089 <https://doi.org/10.1002/ptr.6508>
49. Song G, Lu Y, Yu Z, Xu L, Liu J, Chen K, Zhang P 2019: The inhibitory effect of polysaccharide from Rhizopus nigricans on colitis-associated colorectal cancer. Biomed Pharmacother 112: 108593 <https://doi.org/10.1016/j.biopha.2019.01.054>
50. Takahashi M, Mutoh M, Kawamori T, Sugimura T, Wakabayashi K 2000: Altered expression of β-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis. Carcinogenesis 21: 1319-1327 <https://doi.org/10.1093/carcin/21.7.1319>
51. Takahashi M, Wakabayashi K 2004: Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents. Cancer Sci 95: 475-480 <https://doi.org/10.1111/j.1349-7006.2004.tb03235.x>
52. Tantoy IY, Cataldo JK, Aouizerat BE, Dhruva A, Miaskowski C 2016: A review of the literature on multiple co-occurring symptoms in patients with colorectal cancer who received chemotherapy alone or chemotherapy with targeted therapies. Cancer Nurs 39: 437 <https://doi.org/10.1097/NCC.0000000000000343>
front cover
  • ISSN 0001-7213 (printed)
  • ISSN 1801-7576 (electronic)

Current issue

Archive